Therapeutic advancement of benzothiazole derivatives in the last decennial period.
Animals
Anti-Infective Agents
/ chemical synthesis
Anti-Inflammatory Agents, Non-Steroidal
/ chemical synthesis
Anticonvulsants
/ chemical synthesis
Antimalarials
/ chemical synthesis
Antineoplastic Agents
/ chemical synthesis
Antiviral Agents
/ chemical synthesis
Benzothiazoles
/ chemical synthesis
Humans
Molecular Structure
anti-inflammatory
anticancer
antimicrobial
benzothiazole
biological applications
Journal
Archiv der Pharmazie
ISSN: 1521-4184
Titre abrégé: Arch Pharm (Weinheim)
Pays: Germany
ID NLM: 0330167
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
04
06
2018
revised:
04
10
2018
accepted:
10
10
2018
pubmed:
30
11
2018
medline:
11
4
2019
entrez:
30
11
2018
Statut:
ppublish
Résumé
Benzothiazole, a fused heterocyclic moiety, has attracted synthetic and medicinal chemists for good reasons. It is a valuable scaffold that possesses diverse biological activities, such as anticancer, anti-inflammatory, antimicrobial, antiviral, antimalarial, and anticonvulsant effects. This review mainly focusses on the recent research work on the different biological activities of benzothiazole-based compounds.
Identifiants
pubmed: 30488989
doi: 10.1002/ardp.201800170
doi:
Substances chimiques
Anti-Infective Agents
0
Anti-Inflammatory Agents, Non-Steroidal
0
Anticonvulsants
0
Antimalarials
0
Antineoplastic Agents
0
Antiviral Agents
0
Benzothiazoles
0
benzothiazole
G5BW2593EP
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1800170Informations de copyright
© 2018 Deutsche Pharmazeutische Gesellschaft.